Amgen Inc (AMGN)
269.41
-2.05
(-0.76%)
USD |
NASDAQ |
Sep 21, 16:00
268.43
-0.98
(-0.36%)
After-Hours: 20:00
Amgen Enterprise Value: 171.40B for Sept. 21, 2023
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 21, 2023 | 171.40B |
| September 20, 2023 | 172.50B |
| September 19, 2023 | 168.68B |
| September 18, 2023 | 168.06B |
| September 15, 2023 | 166.76B |
| September 14, 2023 | 167.60B |
| September 13, 2023 | 164.89B |
| September 12, 2023 | 166.54B |
| September 11, 2023 | 167.29B |
| September 08, 2023 | 166.07B |
| September 07, 2023 | 163.37B |
| September 06, 2023 | 160.49B |
| September 05, 2023 | 163.17B |
| September 01, 2023 | 164.61B |
| August 31, 2023 | 164.41B |
| August 30, 2023 | 165.24B |
| August 29, 2023 | 166.18B |
| August 28, 2023 | 164.52B |
| August 25, 2023 | 164.43B |
| August 24, 2023 | 164.56B |
| August 23, 2023 | 164.96B |
| August 22, 2023 | 165.10B |
| August 21, 2023 | 166.74B |
| August 18, 2023 | 167.34B |
| August 17, 2023 | 168.43B |
| Date | Value |
|---|---|
| August 16, 2023 | 169.06B |
| August 15, 2023 | 169.59B |
| August 14, 2023 | 166.89B |
| August 11, 2023 | 167.71B |
| August 10, 2023 | 167.47B |
| August 09, 2023 | 166.01B |
| August 08, 2023 | 166.80B |
| August 07, 2023 | 162.59B |
| August 04, 2023 | 157.43B |
| August 03, 2023 | 150.70B |
| August 02, 2023 | 150.54B |
| August 01, 2023 | 151.46B |
| July 31, 2023 | 152.54B |
| July 28, 2023 | 153.73B |
| July 27, 2023 | 153.56B |
| July 26, 2023 | 153.11B |
| July 25, 2023 | 153.16B |
| July 24, 2023 | 153.22B |
| July 21, 2023 | 152.90B |
| July 20, 2023 | 152.05B |
| July 19, 2023 | 151.42B |
| July 18, 2023 | 151.70B |
| July 17, 2023 | 149.17B |
| July 14, 2023 | 148.95B |
| July 13, 2023 | 149.07B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
108.40B
Minimum
May 31 2019
183.24B
Maximum
Nov 08 2022
150.09B
Average
153.84B
Median
Jun 03 2020
Enterprise Value Benchmarks
| Johnson & Johnson | 407.64B |
| Eli Lilly and Co | 538.31B |
| Merck & Co Inc | 301.41B |
| Pfizer Inc | 206.30B |
| AbbVie Inc | 323.09B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 1.379B |
| Revenue (Quarterly) | 6.986B |
| Total Expenses (Quarterly) | 4.302B |
| EPS Diluted (Quarterly) | 2.57 |
| Gross Profit Margin (Quarterly) | 74.05% |
| Profit Margin (Quarterly) | 19.74% |
| Earnings Yield | 5.50% |
| Operating Earnings Yield | 6.55% |
| Normalized Earnings Yield | 5.505 |